BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37905148)

  • 1. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
    Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
    medRxiv; 2023 Oct; ():. PubMed ID: 37905148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
    Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
    J Thromb Haemost; 2024 Apr; ():. PubMed ID: 38574862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Extracellular Vesicle Tissue Factor Activity During Orthohantavirus Infection Is Associated With Intravascular Coagulation.
    Schmedes CM; Grover SP; Hisada YM; Goeijenbier M; Hultdin J; Nilsson S; Thunberg T; Ahlm C; Mackman N; Fors Connolly AM
    J Infect Dis; 2020 Sep; 222(8):1392-1399. PubMed ID: 31722433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
    Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
    J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
    Hisada Y; Mackman N
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated hemostasis in acute promyelocytic leukemia.
    Hisada Y
    Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients.
    Libourel EJ; Klerk C; van Norden Y; de Maat MP; Kruip MJ; Sonneveld P; Löwenberg B; Leebeek FW
    Thromb Res; 2016 Apr; 140 Suppl 1():S172. PubMed ID: 27161682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
    Nguyen D; Kantarjian HM; Short NJ; Qiao W; Ning J; Cuglievan B; Daver NG; DiNardo CD; Jabbour EJ; Kadia TM; Borthakur G; Garcia-Manero G; Konopleva MY; Andreeff M; Ravandi-Kashani F; Sasaki K; Issa GC
    Cancer; 2023 Jun; 129(12):1856-1865. PubMed ID: 36892949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
    Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
    Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
    Hisada Y; Kawano T; Archibald SJ; Welch JS; Reeves BN; Mackman N
    Blood Adv; 2023 Sep; 7(18):5458-5469. PubMed ID: 37450381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.
    Sakata Y; Murakami T; Noro A; Mori K; Matsuda M
    Blood; 1991 May; 77(9):1949-57. PubMed ID: 1708294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
    Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
    J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the coagulopathies associated with COVID-19 and sepsis.
    Campbell RA; Hisada Y; Denorme F; Grover SP; Bouck EG; Middleton EA; Wolberg AS; Rondina MT; Mackman N
    Res Pract Thromb Haemost; 2021 May; 5(4):e12525. PubMed ID: 34027292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.
    Koschade SE; Stratmann JA; Steffen B; Shaid S; Finkelmeier F; Serve H; Miesbach W; Brandts CH; Ballo O
    Eur J Haematol; 2023 Apr; 110(4):426-434. PubMed ID: 36573351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.
    Hisada Y; Mackman N
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation.
    Keragala CB; McFadyen JD; Ho H; McCutcheon FM; Liu Z; Stevens H; Monagle P; Chunilal S; Medcalf RL; Tran H
    J Thromb Haemost; 2024 Mar; 22(3):785-793. PubMed ID: 37944898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia.
    Li L; Gao L; Wu X; Wu W; Ding Q; Wang X
    Clin Appl Thromb Hemost; 2020; 26():1076029620944471. PubMed ID: 32886527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.